The Secure Drug Supply Chain Act of 2026 is designed to enhance the safety and integrity of the pharmaceutical supply chain in the United States. Its primary objectives are to prevent the importation of unsafe drugs, particularly from countries like China, and to improve transparency and resilience within the drug supply system. The legislation aims to ensure that drugs and their ingredients are sourced responsibly, free from forced labor and violations of U.S. sanctions.